Total Value Stock - Dividend - Research Selection
Market price: 46,41 USD
Total S.A. Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||14.803.000.000|
|Free cash flow||4.039.000.064|
|Liabilities & Shareholders equity||266.132.000.000|
|Diluted shares outstanding||2.621.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||123.318.050.816,00 USD|
|Indices||CAC 40,EURO STOXX 50|
|Raw Data Source||IFRS in Millionen USD|
|Stock Split||2017-12-19,2.0000/1.0000; 2006-05-18,4.0000/1.0000; 1992-02-10,4.0000/1.0000; 1992-02-07,4.000000/1.000000|
Description of the company
Total S.A. is an energy operator. The Company operates through three business segments: an Upstream segment, including alongside the activities of the exploration and production of hydrocarbons, the activities of gas and power; a Refining & Chemicals segment constituting an industrial hub comprising the activities of refining, petrochemicals and specialty chemicals and also includes the activities of oil trading and shipping; a Marketing & Services segment, including the global activities of supply and marketing in the field of petroleum products, as well as the activity of new energies, and a Corporate segment, which includes holdings operating and financial activities. Its projects include CLOV, EGINA, IKIKE, INCAHUASI, LAGGAN-TORMORE, OML-58 UPGRADE, EA-1 AND EA-1A (UGANDA), ELGIN - FRANKLIN REDEVELOPMENT and ABSHERON PH.1, among others.